News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
225,365 Results
Type
Article (5029)
Company Profile (17)
Press Release (220319)
Section
Business (82212)
Career Advice (461)
Deals (15046)
Drug Delivery (8)
Drug Development (19065)
Employer Resources (30)
FDA (3677)
Job Trends (3902)
News (120124)
Policy (7506)
Tag
2024 BioCapital Digital (2)
2024 Biotech Beach Standard (1)
2024 Pharm Country Digital (1)
2025 Lone Star Bio Digital (1)
Academia (292)
Accelerated approval (2)
Adcomms (3)
Allergies (9)
Alliances (14779)
ALS (20)
Alzheimer's disease (247)
Antibody-drug conjugate (ADC) (11)
Approvals (3696)
Artificial intelligence (42)
Autoimmune disease (3)
Automation (3)
Bankruptcy (97)
Best Places to Work (2862)
Biosimilars (11)
Biotechnology (21)
Bladder cancer (9)
Brain cancer (7)
Breast cancer (48)
Cancer (452)
Cardiovascular disease (24)
Career advice (393)
Career pathing (3)
CAR-T (32)
Cell therapy (106)
Cervical cancer (2)
Clinical research (16040)
Collaboration (172)
Compensation (170)
Complete response letters (2)
COVID-19 (302)
CRISPR (8)
C-suite (110)
Cystic fibrosis (16)
Data (525)
Depression (6)
Diabetes (43)
Diagnostics (2041)
Digital health (3)
Diversity, equity & inclusion (12)
Drug discovery (15)
Drug pricing (6)
Drug shortages (1)
Duchenne muscular dystrophy (11)
Earnings (40881)
Editorial (2)
Employer branding (6)
Employer resources (31)
Events (37810)
Executive appointments (314)
FDA (3932)
Featured Employer (6)
Fibrodysplasia Ossificans Progressiva (1)
Frontotemporal dementia (2)
Funding (185)
Gene editing (16)
Generative AI (2)
Gene therapy (53)
GLP-1 (108)
Government (412)
Guidances (17)
Healthcare (5039)
Huntington's disease (1)
IgA nephropathy (4)
Immunology and inflammation (13)
Indications (6)
Infectious disease (318)
Inflammatory bowel disease (24)
Inflation Reduction Act (2)
Influenza (3)
Intellectual property (15)
Interviews (53)
IPO (7825)
IRA (3)
Job creations (1122)
Job search strategy (360)
Kidney cancer (7)
Labor market (5)
Layoffs (100)
Leadership (5)
Legal (2332)
Liver cancer (17)
Lung cancer (54)
Lymphoma (31)
Management (10)
Manufacturing (50)
MASH (28)
Medical device (3861)
Medtech (3862)
Mergers & acquisitions (7428)
Metabolic disorders (123)
Multiple sclerosis (8)
NASH (6)
Neurodegenerative disease (11)
Neuropsychiatric disorders (1)
Neuroscience (344)
NextGen: Class of 2025 (1674)
Non-profit (729)
Northern California (944)
Now hiring (3)
Obesity (53)
Opinion (30)
Ovarian cancer (17)
Pain (13)
Pancreatic cancer (14)
Parkinson's disease (28)
Partnered (4)
Patents (21)
Patient recruitment (31)
Peanut (5)
People (24605)
Pharmaceutical (5)
Pharmacy benefit managers (1)
Phase I (4782)
Phase II (6965)
Phase III (5553)
Pipeline (565)
Policy (9)
Postmarket research (625)
Preclinical (1872)
Press Release (66)
Prostate cancer (27)
Psychedelics (3)
Radiopharmaceuticals (105)
Rare diseases (70)
Real estate (1875)
Recruiting (8)
Regulatory (5125)
Reports (14)
Research institute (301)
Resumes & cover letters (68)
Rett syndrome (4)
Schizophrenia (21)
Series A (28)
Series B (23)
Sickle cell disease (7)
Southern California (712)
Special edition (1)
Spinal muscular atrophy (28)
Sponsored (4)
Startups (1008)
Stomach cancer (1)
Supply chain (10)
Tariffs (5)
United States (7142)
Vaccines (36)
Venture capitalists (2)
Weight loss (21)
Women's health (1)
Date
Today (42)
Last 7 days (210)
Last 30 days (698)
Last 365 days (9960)
2025 (3143)
2024 (11028)
2023 (13193)
2022 (18659)
2021 (19684)
2020 (18243)
2019 (13206)
2018 (10206)
2017 (10008)
2016 (9161)
2015 (12119)
2014 (9592)
2013 (7708)
2012 (8329)
2011 (8796)
2010 (8636)
Location
Africa (184)
Alabama (13)
Alaska (2)
Arizona (59)
Arkansas (1)
Asia (11460)
Australia (1611)
California (1975)
Canada (712)
China (73)
Colorado (84)
Connecticut (94)
Delaware (30)
Europe (24539)
Florida (283)
Georgia (34)
Idaho (23)
Illinois (113)
India (7)
Indiana (64)
Iowa (2)
Japan (72)
Kansas (24)
Kentucky (10)
Louisiana (5)
Maine (40)
Maryland (226)
Massachusetts (1581)
Michigan (85)
Minnesota (139)
Mississippi (1)
Missouri (23)
Montana (16)
Nebraska (12)
Nevada (23)
New Hampshire (16)
New Jersey (570)
New Mexico (5)
New York (478)
North Carolina (330)
North Dakota (3)
Northern California (944)
Ohio (59)
Oklahoma (5)
Oregon (4)
Pennsylvania (349)
Puerto Rico (1)
Rhode Island (13)
South America (276)
South Carolina (5)
Southern California (712)
Tennessee (40)
Texas (229)
Utah (61)
Virginia (46)
Washington D.C. (9)
Washington State (175)
West Virginia (2)
Wisconsin (24)
225,365 Results for "mannkind corporation".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Genetown
Pulmatrix Announces Cross License Agreement and Transfer of Laboratory to MannKind Corporation
Pulmatrix, Inc. announced a series of transactions with MannKind Corporation.
May 29, 2024
·
6 min read
Press Releases
MannKind Corporation Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update
February 27, 2025
·
16 min read
Press Releases
MannKind Corporation to Hold 2024 Fourth Quarter and Full Year Financial Results Conference Call on February 26, 2025
February 20, 2025
·
1 min read
Biotech Beach
MannKind to Establish Boston-Area Research & Development Foothold and Expand Portfolio of Dry Powder Inhalation Technology in Transaction With Pulmatrix
MannKind Corporation announced that it has agreed to in-license iSPERSE™ technology from Pulmatrix for certain indications in exchange for an out-license of MannKind’s Cricket® inhaler to Pulmatrix for inhaled delivery of dihydroergotamine for migraine treatment.
May 29, 2024
·
4 min read
Business
MannKind Corporation Reports 2024 First Quarter Financial Results: Provides Clinical Development UpdateConference Call to Begin Today at 5:00 p.m. (ET)
MannKind Corporation reported financial results for the quarter ended March 31, 2024.
May 8, 2024
·
14 min read
Business
MannKind Corporation to Hold 2024 First Quarter Financial Results Conference Call on May 8, 2024
MannKind Corporation (Nasdaq: MNKD) will release its 2024 first quarter financial results and its management will host a conference call to discuss the financial results and corporate updates at 5:00 PM (Eastern Time) on Wednesday, May 8, 2024.
May 1, 2024
·
1 min read
Press Releases
MannKind Showcases Efficacy, Safety, and Mealtime Control Data from Recent Pediatric and Adult Studies of Afrezza® at the ATTD Conference, March 19-22
March 10, 2025
·
7 min read
Business
MannKind Announces CFO Transition - March 26, 2024
MannKind Corporation announced that Steven B. Binder will retire from his position as Chief Financial Officer, effective April 22, 2024.
March 26, 2024
·
5 min read
Press Releases
MannKind Corporation Reports 2024 Third Quarter Financial Results and Provides Business Update
November 8, 2024
·
19 min read
Drug Development
MannKind to Proceed With Phase 1 Nintedanib Dpi (Mnkd-201) Study for Pulmonary Fibrotic Diseases
MannKind Corporation announced that it will proceed with a first-in-human Phase 1 study of nintedanib DPI for pulmonary fibrotic diseases, including idiopathic pulmonary fibrosis.
April 30, 2024
·
4 min read
1 of 22,537
Next
